Catalyst Pharmaceuticals
CPRX
#3601
Rank
ยฃ2.93 B
Marketcap
ยฃ23.95
Share price
0.00%
Change (1 day)
55.31%
Change (1 year)

P/S ratio for Catalyst Pharmaceuticals (CPRX)

P/S ratio on November 18, 2026 (TTM) : 6.46

According to Catalyst Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.81. At the end of 2026 the company had a P/S ratio of 4.82.

P/S ratio history for Catalyst Pharmaceuticals from 2010 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20264.82-0.27%
20254.83-7.23%
20245.2115.71%
20234.50-50.2%
20229.0482.53%
20214.9570.08%
20202.91-23.19%
20193.79-99.04%
2018395
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A
2012N/A
2011N/A-100%
201039.3

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
6.66 3.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
2.52-60.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3.86-40.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
0.7992-87.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
0.0071-99.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.22-50.18%๐Ÿ‡บ๐Ÿ‡ธ USA